ArticleJournal of enzyme inhibition and medicinal chemistry2018

A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma.

Guangwei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.